Detalles de la búsqueda
1.
Recommended data elements for health registries: a survey from a German funding initiative.
BMC Med Inform Decis Mak
; 24(1): 136, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802886
2.
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
Kidney Int
; 104(3): 552-561, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343659
3.
Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study).
Nephrol Dial Transplant
; 39(1): 141-150, 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391381
4.
Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.
Kidney Int
; 101(3): 597-606, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953772
5.
Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results.
Eur J Immunol
; 51(4): 943-955, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33306229
6.
Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography.
J Nucl Cardiol
; 29(6): 2988-2999, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750727
7.
[Safety of the Living Kidney Donor - The German National Register - Development and Structure of a National Register in the Health Service Research]. / Die Sicherheit des Lebendnierenspenders Das Deutsche Lebendspende Register SOLKID-GNR Entstehung und Struktur eines nationalen Registers in der Versorgungsforschung.
Gesundheitswesen
; 83(S 01): S33-S38, 2021 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-34731891
8.
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Kidney Int
; 96(1): 231-244, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31027892
9.
Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
Clin Transplant
; 32(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29052906
10.
Investigation of the physical and psychosocial outcomes after living kidney donation - a multicenter cohort study (SoLKiD - Safety of Living Kidney Donors).
BMC Nephrol
; 19(1): 83, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29631543
11.
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
BMC Nephrol
; 19(1): 237, 2018 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231851
12.
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.
BMC Nephrol
; 19(1): 154, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954336
13.
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.
Nephrol Dial Transplant
; 32(5): 880-889, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340245
14.
Rescue allocation and recipient oriented extended allocation in kidney transplantation-influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially nonaccepted organs.
Transpl Int
; 30(12): 1226-1233, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28574620
15.
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial.
Clin Nephrol
; 85(4): 215-25, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932178
16.
Early postoperative calculation of the tacrolimus concentration-to-dose ratio does not predict outcomes after kidney transplantation.
Transpl Int
; 33(6): 689-691, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163653
17.
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.
Clin Nephrol
; 83(1): 11-21, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512099
18.
Valganciclovir is not a risk factor of BK polyomavirus viremia.
Am J Transplant
; 19(12): 3436-3437, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556235
19.
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
Transpl Int
; 27(1): 77-86, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24164420
20.
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.
Transpl Int
; 27(11): 1192-204, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25070687